Research Top

Saving tiny Hearts Research


The primary purpose of the Saving tiny Hearts Society is to raise money to fund life saving research projects to improve, prolong and save the lives of those affected by Congenital Heart Defects.

We are honored to have a Medical Advisory Board (MAB) comprised of an elite group of world-renowned cardiothoracic surgeons, researchers and cardiologists. The MAB vets and determines which research projects the Saving tiny Hearts Society will fund. With the help of our MAB, money raised is allocated to fund the most promising research of number one birth defect worldwide.

2017 Grant Application

The Saving tiny Hearts Society awards research grants to early stage science with unique hypotheses
fostering the next generation of congenital heart defect research creating a strong foundation of
preliminary evidence to make scientific advancements.

As a private, not-for-profit source of funds for scientists studying congenital heart defects, the Saving
tiny Hearts Society focuses its funding on investigator-initiated, peer-reviewed proposals. This process
ensures that researchers propose projects they believe are ready to be tackled with the available
knowledge and techniques. This intellectual freedom encourages discovery in areas that scientists
believe are most likely to determine hidden causes and discover cures to prolong, improve and save the
lives of all children afflicted with congenital heart defects.

To streamline the grant application process, an electronic link has been provided below to download the
Saving tiny Hearts Society 2017 Grant Application. If you have additional questions regarding our
application process, please email, Larry Kluge, Medical Advisory Board Liaison at:
2017 Grant Application PDF IconDownload the 2017 Grant Application


Projects Funded

2014 – 2015
($200,000 total allocation)

Arrhythmogenic Substrate in Fontan Patients

Hypoplastic Left Heart Syndrome

Cardiac defects in LEOPARD Syndrome

2013 – 2014
($200,000 total allocation)

Long QT Vulnerability in SIDS

Notch Signaling & Ascending Aortic Aneurysm

Novel Mouse Model for CHD and Heterotaxy

Early Manifestation of AC in Children


2012 – 2013
($190,000 total allocation)

Early Manifestations of AC in Children

Improving Prenatal Screening for CHD

Augmenting O-GlcNAcylation

Myosin Heavy Chain 7 Mutation and HC

Arrhythmia & Sudden Cardiac Death in Children

2011 – 2012
($244,000 total allocation)

Arrhythmia and Sudden Cardiac Death in Children

Pulmonary Venous Obstruction in CHD

Brain MRI Atlas for Infants with CHD



2010 – 2011
($344,156 total allocation)

Mechanisms in the Pathogenesis of HLHS

Hypoxia on Neuro Outcome in CHD

Unbalanced Atrioventricular Septal Defect

3D Cardiac Tissue Engineering

2009 – 2010
($100,000 total allocation)

3D Tissue Engineering

2007 – 2009
($52,000 total allocation)

Myocardial Protection and Support in Cyanotic CHD